Skip to content
HowShorted

Viking Therapeutics, Inc. short interest in 2026

In 2026, Viking Therapeutics, Inc.'s disclosed short interest ran from 22.23% of shares outstanding on 15 Jan 2026 to 19.36% on 15 Sep 2026, a change of -2.87 percentage points. The year's high was 23.06% on 30 Jan 2026 and its low 19.02% on 31 Aug 2026, averaging 20.33% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.30 days on 14 Aug 2026. Full history: Viking Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Viking Therapeutics, Inc. in 2026

2026 in figures

Start of year
22.23% (15 Jan 2026)
End of year
19.36% (15 Sep 2026)
Change
-2.87 pp
High
23.06% (30 Jan 2026)
Low
19.02% (31 Aug 2026)
Average
20.33%
Highest days to cover
13.30 (14 Aug 2026)
SEC filings marked
6

Every report in 2026

Viking Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202622.23%5.97
30 Jan 202623.06%9.88
13 Feb 202622.64%6.9310-K filed, results (8-K)
27 Feb 202621.05%10.84
13 Mar 202621.03%9.88
31 Mar 202620.77%9.82
15 Apr 202619.90%11.05
30 Apr 202619.51%8.92results (8-K), 10-Q filed
15 May 202619.19%11.20
29 May 202619.27%11.69
15 Jun 202620.08%11.64
30 Jun 202620.25%6.65
15 Jul 202619.85%9.84
31 Jul 202619.32%10.4910-Q filed, results (8-K)
14 Aug 202619.10%13.30
31 Aug 202619.02%12.39
15 Sep 202619.36%12.32

See also: Viking Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.